Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Financial Results

    Financial Results - Page 11

    Cipla Q3 profit rises about 7 percent to Rs 401 crore

    Cipla Q3 profit rises about 7 percent to Rs 401 crore

    Ruby Khatun Khatun9 Feb 2018 11:00 AM IST
    Mumbai: Leading drugmaker, Cipla said its net profit rose 7 percent at Rs 401 crore in the third-quarter ended December due to strong sales in India,...
    Natco Pharma Q3 net profit up 12 percent at Rs 217.4 crore

    Natco Pharma Q3 net profit up 12 percent at Rs 217.4 crore

    Medical Dialogues Bureau7 Feb 2018 10:30 AM IST
    New Delhi: Drug firm Natco Pharma reported an 11.54 percent rise in its consolidated profit after tax at Rs 217.4 crore for the quarter ended December...
    Lupin Q3 net profit dips 65 percent to Rs 222 crore

    Lupin Q3 net profit dips 65 percent to Rs 222 crore

    Ruby Khatun Khatun7 Feb 2018 10:17 AM IST
    New Delhi: Drug firm Lupin reported 64.97 percent fall in consolidated net profit at Rs 221.73 crore for the quarter ended December 31, mainly on...
    AstraZeneca profits down due to loss of key patents in US

    AstraZeneca profits down due to loss of key patents in US

    Ruby Khatun Khatun5 Feb 2018 9:30 AM IST
    London: AstraZeneca said that net profits slid in 2017, as it continued to be hit by the loss of exclusivity on key blockbuster drugs in the United...
    Alembic Pharma Q3 net profit rises 52 percent to Rs 131 crore

    Alembic Pharma Q3 net profit rises 52 percent to Rs 131 crore

    Ruby Khatun Khatun2 Feb 2018 10:15 AM IST
    New Delhi: Drug firm Alembic Pharmaceuticals reported a 52.32 percent jump in its consolidated net profit to Rs 131 crore for the third quarter ended...
    Dabur India Q3 net profit up 13 percent to Rs 333 crore

    Dabur India Q3 net profit up 13 percent to Rs 333 crore

    Ruby Khatun Khatun2 Feb 2018 9:30 AM IST
    New Delhi: Dabur India reported 13 percent rise in consolidated net profit at Rs 333.05 crore for the third quarter ended December 31, led by strong...
    Novartis India Q3 net profit up 44 percent at Rs 18.74 crore

    Novartis India Q3 net profit up 44 percent at Rs 18.74 crore

    Ruby Khatun Khatun31 Jan 2018 10:30 AM IST
    New Delhi: Novartis India reported a 43.82% increase in net profit at Rs18.74 crore for the third quarter ended December 2017.The company had posted a...
    Ajanta Pharma Q3 net profit up 3 percent at Rs 147.47 crore

    Ajanta Pharma Q3 net profit up 3 percent at Rs 147.47 crore

    Medical Dialogues Bureau28 Jan 2018 11:00 AM IST
    New Delhi: Drug firm Ajanta Pharma reported a 3.41 percent rise in its consolidated net profit to Rs 147.47 crore for the quarter ended December 31,...
    Biocon net profit plunges 46 percent in Q3

    Biocon net profit plunges 46 percent in Q3

    Ruby Khatun Khatun27 Jan 2018 11:00 AM IST
    New Delhi: Shares of biotechnology major Biocon dropped by over 4 percent after the company reported a 46.35 percent dip in consolidated net profit...
    Dr Reddys Q3 net profit falls 38 percent to Rs 303 crore

    Dr Reddy's Q3 net profit falls 38 percent to Rs 303 crore

    Medical Dialogues Bureau27 Jan 2018 10:30 AM IST
    New Delhi: Dr Reddy's Laboratories posted a 38.51 percent decline in consolidated net profit at Rs 302.7 crore for the third quarter ended December...
    Abbott results beat on strong medical device business

    Abbott results beat on strong medical device business

    Medical Dialogues Bureau27 Jan 2018 9:45 AM IST
    Abbott Laboratories' fourth-quarter results topped analysts' estimates, boosted by strong sales in its medical devices and generics businesses.Shares...
    Pfizer Q3 net profit up 40 percent at Rs 87 crore

    Pfizer Q3 net profit up 40 percent at Rs 87 crore

    Medical Dialogues Bureau25 Jan 2018 11:00 AM IST
    New Delhi: Drug firm Pfizer reported a 39.87 percent rise in its net profit at Rs 87.24 crore for the quarter ended December 2017, mainly on account...
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Indira IVF to invest Rs 80 crore to expand presence in south India by 2020

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    Aurobindo Pharma gets USFDA nod for Fluoxetine Tablets

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    Aurobindo Pharma targets to achieve zero debt in three years sans Novartis deal

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    SoftBank leads USD 165 million capital boost for liquid biopsy firm Karius

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok